nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP1A1—polycystic ovary syndrome	0.615	1	CbGaD
Dapagliflozin—SLC5A4—urine—polycystic ovary syndrome	0.0454	0.284	CbGeAlD
Dapagliflozin—SLC5A2—urine—polycystic ovary syndrome	0.0344	0.215	CbGeAlD
Dapagliflozin—Angina unstable—Metformin—polycystic ovary syndrome	0.00906	0.244	CcSEcCtD
Dapagliflozin—SLC5A11—pituitary gland—polycystic ovary syndrome	0.00882	0.0552	CbGeAlD
Dapagliflozin—SLC5A1—endometrium—polycystic ovary syndrome	0.00616	0.0386	CbGeAlD
Dapagliflozin—SLC5A2—vagina—polycystic ovary syndrome	0.00609	0.0381	CbGeAlD
Dapagliflozin—SLC5A2—endocrine gland—polycystic ovary syndrome	0.0057	0.0357	CbGeAlD
Dapagliflozin—SLC5A1—pituitary gland—polycystic ovary syndrome	0.00558	0.0349	CbGeAlD
Dapagliflozin—CYP1A2—urine—polycystic ovary syndrome	0.00498	0.0311	CbGeAlD
Dapagliflozin—CYP2C9—urine—polycystic ovary syndrome	0.00472	0.0296	CbGeAlD
Dapagliflozin—SLC5A1—vagina—polycystic ovary syndrome	0.00462	0.0289	CbGeAlD
Dapagliflozin—UGT2B4—endocrine gland—polycystic ovary syndrome	0.00398	0.0249	CbGeAlD
Dapagliflozin—CYP3A4—urine—polycystic ovary syndrome	0.0036	0.0225	CbGeAlD
Dapagliflozin—CYP2D6—urine—polycystic ovary syndrome	0.00354	0.0222	CbGeAlD
Dapagliflozin—Fungal infection—Metformin—polycystic ovary syndrome	0.00297	0.0799	CcSEcCtD
Dapagliflozin—UGT1A9—endocrine gland—polycystic ovary syndrome	0.00272	0.017	CbGeAlD
Dapagliflozin—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00219	0.0137	CbGeAlD
Dapagliflozin—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00202	0.0126	CbGeAlD
Dapagliflozin—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0017	0.0459	CcSEcCtD
Dapagliflozin—CYP2A6—vagina—polycystic ovary syndrome	0.00168	0.0105	CbGeAlD
Dapagliflozin—Pain in extremity—Metformin—polycystic ovary syndrome	0.00166	0.0448	CcSEcCtD
Dapagliflozin—Dehydration—Metformin—polycystic ovary syndrome	0.00155	0.0417	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00149	0.0401	CcSEcCtD
Dapagliflozin—Influenza—Metformin—polycystic ovary syndrome	0.00144	0.0387	CcSEcCtD
Dapagliflozin—Angina pectoris—Metformin—polycystic ovary syndrome	0.0014	0.0377	CcSEcCtD
Dapagliflozin—Infestation—Metformin—polycystic ovary syndrome	0.00128	0.0345	CcSEcCtD
Dapagliflozin—Infestation NOS—Metformin—polycystic ovary syndrome	0.00128	0.0345	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00113	0.0305	CcSEcCtD
Dapagliflozin—CYP1A1—uterus—polycystic ovary syndrome	0.00107	0.00669	CbGeAlD
Dapagliflozin—CYP1A1—adipose tissue—polycystic ovary syndrome	0.00105	0.00655	CbGeAlD
Dapagliflozin—Malnutrition—Metformin—polycystic ovary syndrome	0.001	0.027	CcSEcCtD
Dapagliflozin—CYP1A1—female gonad—polycystic ovary syndrome	0.000875	0.00548	CbGeAlD
Dapagliflozin—CYP1A1—vagina—polycystic ovary syndrome	0.00087	0.00544	CbGeAlD
Dapagliflozin—Hypertension—Metformin—polycystic ovary syndrome	0.000864	0.0233	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000846	0.0228	CcSEcCtD
Dapagliflozin—Discomfort—Metformin—polycystic ovary syndrome	0.000842	0.0227	CcSEcCtD
Dapagliflozin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000825	0.00516	CbGeAlD
Dapagliflozin—ABCB1—embryo—polycystic ovary syndrome	0.000824	0.00516	CbGeAlD
Dapagliflozin—Oedema—Metformin—polycystic ovary syndrome	0.000817	0.022	CcSEcCtD
Dapagliflozin—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000814	0.00509	CbGeAlD
Dapagliflozin—Infection—Metformin—polycystic ovary syndrome	0.000812	0.0219	CcSEcCtD
Dapagliflozin—Skin disorder—Metformin—polycystic ovary syndrome	0.000794	0.0214	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00079	0.0213	CcSEcCtD
Dapagliflozin—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000783	0.0049	CbGeAlD
Dapagliflozin—Hypotension—Metformin—polycystic ovary syndrome	0.000763	0.0206	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000705	0.019	CcSEcCtD
Dapagliflozin—Constipation—Metformin—polycystic ovary syndrome	0.000699	0.0188	CcSEcCtD
Dapagliflozin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000675	0.00423	CbGeAlD
Dapagliflozin—Urticaria—Metformin—polycystic ovary syndrome	0.000649	0.0175	CcSEcCtD
Dapagliflozin—CYP2D6—female gonad—polycystic ovary syndrome	0.000632	0.00395	CbGeAlD
Dapagliflozin—ABCB1—endometrium—polycystic ovary syndrome	0.000603	0.00377	CbGeAlD
Dapagliflozin—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000597	0.00374	CbGeAlD
Dapagliflozin—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000588	0.00368	CbGeAlD
Dapagliflozin—ABCB1—uterus—polycystic ovary syndrome	0.000556	0.00348	CbGeAlD
Dapagliflozin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000546	0.00341	CbGeAlD
Dapagliflozin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000543	0.0034	CbGeAlD
Dapagliflozin—Dizziness—Metformin—polycystic ovary syndrome	0.00054	0.0146	CcSEcCtD
Dapagliflozin—Rash—Metformin—polycystic ovary syndrome	0.000515	0.0139	CcSEcCtD
Dapagliflozin—Dermatitis—Metformin—polycystic ovary syndrome	0.000515	0.0139	CcSEcCtD
Dapagliflozin—Headache—Metformin—polycystic ovary syndrome	0.000512	0.0138	CcSEcCtD
Dapagliflozin—ABCB1—adrenal gland—polycystic ovary syndrome	0.000487	0.00305	CbGeAlD
Dapagliflozin—Nausea—Metformin—polycystic ovary syndrome	0.000485	0.0131	CcSEcCtD
Dapagliflozin—ABCB1—female gonad—polycystic ovary syndrome	0.000455	0.00284	CbGeAlD
Dapagliflozin—ABCB1—vagina—polycystic ovary syndrome	0.000452	0.00283	CbGeAlD
Dapagliflozin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000423	0.00265	CbGeAlD
Dapagliflozin—UGT1A9—Metabolism—YAP1—polycystic ovary syndrome	4.09e-05	0.000217	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	4.07e-05	0.000217	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.04e-05	0.000215	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	3.96e-05	0.000211	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	3.96e-05	0.000211	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.93e-05	0.000209	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	3.93e-05	0.000209	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	3.92e-05	0.000209	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	3.92e-05	0.000209	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	3.91e-05	0.000208	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.9e-05	0.000208	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	3.9e-05	0.000208	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	3.88e-05	0.000206	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	3.87e-05	0.000206	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.85e-05	0.000205	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—TH—polycystic ovary syndrome	3.84e-05	0.000204	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.8e-05	0.000202	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	3.79e-05	0.000201	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.75e-05	0.000199	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SLC2A4—polycystic ovary syndrome	3.73e-05	0.000199	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.73e-05	0.000199	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	3.72e-05	0.000198	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.7e-05	0.000197	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.7e-05	0.000197	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	3.68e-05	0.000196	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.68e-05	0.000196	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	3.67e-05	0.000195	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	3.67e-05	0.000195	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	3.67e-05	0.000195	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	3.67e-05	0.000195	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	3.66e-05	0.000195	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	3.61e-05	0.000192	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.6e-05	0.000192	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.55e-05	0.000189	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.52e-05	0.000188	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYP19A1—polycystic ovary syndrome	3.51e-05	0.000187	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.5e-05	0.000186	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.47e-05	0.000185	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	3.38e-05	0.00018	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.36e-05	0.000179	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.34e-05	0.000178	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	3.32e-05	0.000177	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.29e-05	0.000175	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	3.27e-05	0.000174	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.25e-05	0.000173	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.19e-05	0.00017	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	3.17e-05	0.000168	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	3.15e-05	0.000168	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GNAS—polycystic ovary syndrome	3.13e-05	0.000167	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	3.13e-05	0.000167	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	3.13e-05	0.000167	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.13e-05	0.000166	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—TH—polycystic ovary syndrome	3.12e-05	0.000166	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	3.12e-05	0.000166	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—IL6—polycystic ovary syndrome	3.11e-05	0.000166	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—IL6—polycystic ovary syndrome	3.11e-05	0.000166	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	3.1e-05	0.000165	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	3.07e-05	0.000163	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.06e-05	0.000163	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.06e-05	0.000163	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	3.03e-05	0.000161	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	3.03e-05	0.000161	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.01e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	2.99e-05	0.000159	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	2.99e-05	0.000159	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.97e-05	0.000158	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.97e-05	0.000158	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.96e-05	0.000158	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.94e-05	0.000156	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	2.91e-05	0.000155	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	2.89e-05	0.000154	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	2.85e-05	0.000152	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.84e-05	0.000151	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.83e-05	0.000151	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	2.83e-05	0.000151	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	2.82e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.82e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.8e-05	0.000149	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	2.78e-05	0.000148	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	2.78e-05	0.000148	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.75e-05	0.000146	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.73e-05	0.000145	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.66e-05	0.000141	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.65e-05	0.000141	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	2.64e-05	0.00014	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.62e-05	0.00014	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	2.55e-05	0.000136	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.53e-05	0.000135	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.51e-05	0.000134	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.5e-05	0.000133	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.49e-05	0.000133	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.49e-05	0.000132	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	2.48e-05	0.000132	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	2.44e-05	0.00013	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	2.43e-05	0.000129	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.42e-05	0.000129	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.42e-05	0.000129	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TH—polycystic ovary syndrome	2.4e-05	0.000128	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.38e-05	0.000127	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.37e-05	0.000126	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	2.36e-05	0.000126	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	2.35e-05	0.000125	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.35e-05	0.000125	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	2.34e-05	0.000124	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.33e-05	0.000124	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.31e-05	0.000123	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	2.3e-05	0.000122	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.26e-05	0.00012	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.25e-05	0.00012	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.24e-05	0.000119	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.23e-05	0.000119	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.21e-05	0.000118	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.21e-05	0.000118	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	2.2e-05	0.000117	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.18e-05	0.000116	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.17e-05	0.000116	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.15e-05	0.000115	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	2.14e-05	0.000114	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	2.14e-05	0.000114	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.12e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.12e-05	0.000113	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	2.11e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2.11e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.1e-05	0.000112	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—INS—polycystic ovary syndrome	2.1e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.07e-05	0.00011	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.06e-05	0.000109	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	2.04e-05	0.000108	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.03e-05	0.000108	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.02e-05	0.000107	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	2.01e-05	0.000107	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.99e-05	0.000106	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	1.96e-05	0.000104	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.95e-05	0.000104	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.92e-05	0.000102	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.89e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.89e-05	0.000101	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.88e-05	9.98e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.88e-05	9.98e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	1.87e-05	9.95e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.84e-05	9.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.83e-05	9.75e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.83e-05	9.75e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.82e-05	9.67e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.8e-05	9.59e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.8e-05	9.57e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.79e-05	9.53e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.78e-05	9.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	1.77e-05	9.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.77e-05	9.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.75e-05	9.32e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.74e-05	9.27e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.74e-05	9.27e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	1.74e-05	9.25e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	1.71e-05	9.12e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—INS—polycystic ovary syndrome	1.71e-05	9.07e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.7e-05	9.03e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	1.68e-05	8.96e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.68e-05	8.94e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.68e-05	8.92e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.67e-05	8.9e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	1.66e-05	8.84e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.65e-05	8.8e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	1.65e-05	8.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.65e-05	8.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.64e-05	8.72e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.63e-05	8.69e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.6e-05	8.53e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.58e-05	8.42e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	1.57e-05	8.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.56e-05	8.29e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.56e-05	8.29e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.55e-05	8.26e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	1.55e-05	8.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.5e-05	7.96e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.46e-05	7.78e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.44e-05	7.65e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.43e-05	7.62e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.43e-05	7.61e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.42e-05	7.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.42e-05	7.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.41e-05	7.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.39e-05	7.41e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.39e-05	7.41e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.39e-05	7.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.35e-05	7.18e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.34e-05	7.15e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.34e-05	7.14e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	1.34e-05	7.13e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.34e-05	7.11e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	1.32e-05	7.03e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.32e-05	7.03e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—INS—polycystic ovary syndrome	1.31e-05	6.99e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.31e-05	6.98e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.31e-05	6.96e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	6.92e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.24e-05	6.58e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.23e-05	6.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.23e-05	6.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.22e-05	6.51e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.2e-05	6.38e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.17e-05	6.22e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.16e-05	6.15e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.14e-05	6.08e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.11e-05	5.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.11e-05	5.91e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.11e-05	5.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.1e-05	5.86e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.1e-05	5.83e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	5.81e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.06e-05	5.61e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.05e-05	5.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.04e-05	5.56e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	5.53e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.04e-05	5.51e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.02e-05	5.42e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	9.99e-06	5.31e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	9.94e-06	5.29e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	9.86e-06	5.24e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	9.85e-06	5.24e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.84e-06	5.23e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—INS—polycystic ovary syndrome	9.79e-06	5.21e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	9.33e-06	4.96e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	9.27e-06	4.93e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	9.19e-06	4.89e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	8.88e-06	4.73e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.82e-06	4.69e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.58e-06	4.56e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	8.42e-06	4.48e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	8.06e-06	4.29e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	7.98e-06	4.24e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.87e-06	4.19e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	7.85e-06	4.18e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.82e-06	4.16e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.52e-06	4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	7.45e-06	3.96e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	7.41e-06	3.94e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—INS—polycystic ovary syndrome	7.37e-06	3.92e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	7.35e-06	3.91e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—INS—polycystic ovary syndrome	7.31e-06	3.89e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	7.2e-06	3.83e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.86e-06	3.65e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.5e-06	3.46e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	6.37e-06	3.39e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	6.28e-06	3.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	6.24e-06	3.32e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.06e-06	3.22e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.91e-06	2.61e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.85e-06	2.58e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.82e-06	2.56e-05	CbGpPWpGaD
